Granata Bio ("Granata"), a U.S.-based biotechnology company focused on advancing fertility therapeutics, today announced a strategic partnership with Gedeon Richter Plc. ("Richter"), a global leader ...

The Food and Drug Administration says that a prominent medical contrarian and critic of the drug industry will head its ...

Galapagos NV (Euronext & NASDAQ: GLPG), a global biotechnology company dedicated to transforming patient outcomes through life-changing science and innovation, today provides a strategic update on the ...

"The difference between living or dying can rest on whether or not the doctor knows about a particular condition." ...

The president signed an executive order Friday calling for several sweeping changes in VA operations and construction goals.

Social media is awash with content promoting grounding mats and sheets. Could they really help you sleep better?

Discover Agenus Inc.'s Q1 2025 highlights, including groundbreaking BOT/BAL data, strategic transactions, financial updates, and insights on ...

Pivotal Advance-HTN and Launch-HTN trials successfully achieved statistical significance in primary efficacy endpoints and demonstrated a favorable safety and tolerability profile – – Anticipate ...

Mineralys Therapeutics, Inc. ( NASDAQ: MLYS) Q1 2025 Earnings Conference Call May 12, 2025 4:30 PM ET ...

IND application submission on track for Q2 2025: MBX 4291, a GLP-1/GIP co-agonist prodrug, is being developed as a once-monthly treatment for obesity. The Company expects to submit an IND application ...

She underwent treatment during the Covid pandemic and was often isolated due to restrictions on hospital visits. As the ...

Feature / Democrats love to avoid it, and Republicans love to lie about it. But later-abortion care has never been more ...